Resources

The Australian National University's Recombinant DNA Monitoring Committee sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

The Australian Pesticides and Veterinary Medicines Authority sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

AusBiotech sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

The Australian Academy of Science and the Australian Academy of Technology and Engineering sent this joint submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

The Australian Seed Federation sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

BASF sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

CropLife Australia sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

Gene Ethics sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

Queensland University of Technology sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

The Royal Prince Alfred Hospital's Institutional Biosafety Committee sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

The Rare Disease Industry Working Group sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

Western Australia's Department of Primary Industries and Regional Development sent this submission for the scheme’s third review consultation about a ‘Regulation impact statement’ and ‘Explanatory paper’ directly to the secretariat.

This consultation regulation impact statement presents 2 options for implementing key recommendations of the 2017 review through a proposed regulatory framework.

This document is a summary of the Gene Technology Ministers’ Meeting (GTMM) held on Tuesday 20 July 2021.

This decision regulation impact statement outlines 3 policy options to implement the recommendations of the third review of the National Gene Technology Scheme.

This updated action plan for implementing recommendations from the 2017 review of the National Gene Technology Scheme takes into account changes arising from the 2020 review of COAG councils and ministerial forms.

This fact sheet contains a selection of questions and answers that address key issues raised during information sessions. The information sessions covered the consultation regulation impact statement and explanatory paper – part of the 2017 review of the National Gene Technology Scheme.

This communique outlines the outcomes from the meeting held on 11 December 2020. The forum is now known as the Gene Technology Ministers’ Meeting.

CropLife Australia sent this submission for the Issues paper consultation of the third review directly by the Gene Technology secretariat.

Gene Ethics and Friends of the Earth Australia sent a joint submission for the Issues paper consultation of the third review directly by the Gene Technology secretariat.

The Australian Seed Federation sent this submission for the Issues paper consultation of the third review directly by the Gene Technology secretariat.

BASF sent this submission for the Issues paper consultation of the third review directly by the Gene Technology secretariat.

La Trobe University's Institutional Biosafety Committee sent this second submission for the Issues paper consultation of the third review directly by the Gene Technology secretariat. Their first submission was lodged via the Consultation Hub.